KAY-ANN MCLEAN: Open Payments
NPI 1144883232 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,918 in 146 payments from 14 companies in 2025. Trend: 2023 $1,022 · 2024 $3,303 · 2025 $2,918
Food & beverage: $2,918
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 62 | $1,514 |
| Madrigal Pharmaceuticals | 21 | $496 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $209 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $104 |
| Phathom Pharmaceuticals, Inc. | 17 | $101 |
| Ardelyx, Inc. | 5 | $99 |
| GENZYME CORPORATION | 4 | $98 |
| Regeneron Healthcare Solutions, Inc. | 4 | $92 |
| Aimmune Therapeutics, Inc. | 3 | $48 |
| Gilead Sciences, Inc. | 2 | $43 |
Products named: RINVOQ, REZDIFFRA, SKYRIZI, DUPIXENT, CREON, XIFAXAN, ENTYVIO, VOQUEZNA.
Industry payments across AL — which companies pay providers there.
